GORDON A. CAIN FOR LEXICON GENETICS INCORPORATED

Company

LEXICON PHARMACEUTICALS, INC.

Filed

March 9, 2001

Accession Number

0000950129-01-001338

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →